Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 11,520 shares at $21.73 ($250K) on 2024-12-02, disclosed to the SEC on 2024-12-02.
Scheduled sale ($250k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.73 | 5,760 | $125K | 50.0% |
| 2 | $21.73 | 5,760 | $125K | 50.0% |
| Total | $21.73 avg | 11,520 | $250K | 100% |
| Filing → |
| NRIX | SELL | 2026-08-03 | $382K | — | Filing → |
| NRIX | SELL | 2026-07-30 | $90K | — | Filing → |
| NRIX | SELL | 2026-07-02 | $259K | — | Filing → |